UPDATE
Humana Commercial Plan Exit Guide
In 2023, Humana announced its complete exit from the commercial medical insurance market to sharpen its focus on government-sponsored programs like Medicare and Medicaid. This strategic shift involves an 18–24 month transition period as existing employer-sponsored plans phase out. For IBCLCs, this means a significant pivot: patient participation will now center almost exclusively on Medicaid managed care and other government products, requiring practitioners to realign their payer strategies immediately.
Understanding the Impact
Following Humana's 2023 exit from the employer-sponsored commercial market, many IBCLCs noted a sharp decline in Humana patients. This 'disappearance' marks the end of traditional commercial contracts, effectively shifting the landscape for practitioners. For most IBCLCs, existing commercial agreements are phasing out alongside the transition period ending in 2025.
Moving forward, Humana participation for lactation consultants will center exclusively on their government-sponsored program of Medicaid Managed Care. Understanding this shift is critical for maintaining patient access, as these patients can no longer be serviced under older commercial fee schedules or contracts.
Action Plan for Practitioners
State Product Check
Start by verifying Humana's remaining products in your state. Focus on differentiating Medicaid managed care from departing commercial coverage to ensure uninterrupted patient support.
Medicaid Alignment
Deepen your understanding of Medicaid managed care requirements. Review existing contracts to align with Humana's shift toward government-sponsored programs and managed CARE models.
Strategic Review
Conduct a comprehensive review of your payer strategy. Align your Humana participation with long-term practice goals to ensure financial sustainability through the 18-24 month transition.